chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: Numbness in different parts of tongue.; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 06Apr2021 at 09:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to onions and the patient had no other relevant medical history. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 12:00, the patient experienced numbness in different parts of tongue. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event numbness in different parts of tongue was resolved on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Dizziness; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ED7533), via an unspecified route of administration in the right arm on 31Mar2021 at 14:30 (at the age of 38-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient did not have any history of allergies to medications, food, or other products. Concomitant medications included finasteride (MANUFACTURER UNKNOWN), pentoxifylline (TRENTAL), omeprazole (MANUFACTURER UNKNOWN) and chondroitin sulfate; glucosamine hydrochloride (OSTEO BI-FLEX). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 06:00, the patient experienced dizziness and nausea. No therapeutics measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dizziness and nausea was not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Hypoacusis, Pharyngeal hypoaesthesia
Clinical narrative: ears to throat felt very numb; ears felt very muffled; could not swallow for several minutes; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 27Mar2021 at 10:45 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included gerd, shellfish allergy and allergic to NSAIDS. Concomitant medications included unspecified medication used within two weeks prior to vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 10:45, the patient experienced ears to throat felt very numb, ears felt very muffled (for 2 weeks and still feel this way) and could not swallow for several minutes (suddenly was able to swallow). No therapeutic measures were taken as a result of the events. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events very numb, ears felt very muffled and could not swallow for several minutes was recovered/resolved with sequelae at the time of the report.  No follow-up attempts are needed; information about the lot number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Pain, Pain in extremity
Clinical narrative: Runny nose; Sleepy; Sore and achy body; "Left arm is sore"; Mild headache; Very tired; Mild diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP-6955) via an unspecified route of administration in the left arm on 08Apr2021 at 13:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included sjogren's (rheumatological condition) and allergy to bee stings. The patient received unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP-6955) via an unspecified route of administration in the left arm on 18Mar2021 at 13:15 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 07:00, the patient's left arm was sore and experienced mild headache, runny nose, sore and achy body, mild diarrhoea and was very tired/sleepy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events "left arm is sore", mild headache, runny nose, very tired, sleepy, sore and achy body and mild diarrhoea were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Somnolence
Clinical narrative: Runny nose; Sleepy; Sore and achy body; "Left arm is sore"; Mild headache; Very tired; Mild diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP-6955) via an unspecified route of administration in the left arm on 08Apr2021 at 13:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included sjogren's (rheumatological condition) and allergy to bee stings. The patient received unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP-6955) via an unspecified route of administration in the left arm on 18Mar2021 at 13:15 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 07:00, the patient's left arm was sore and experienced mild headache, runny nose, sore and achy body, mild diarrhoea and was very tired/sleepy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events "left arm is sore", mild headache, runny nose, very tired, sleepy, sore and achy body and mild diarrhoea were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pain in extremity, Urticaria
Clinical narrative: diarrhea; Mild itchy hives on the neck; Sore left arm; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 03Apr2021 at 12:45 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history included bronchitis [hospitalization for bronchitis for 10 days at the age of 11 (15 years ago Concomitant medications included norethisterone acetate (NORETHINDRONE) from an unknown date for an unknown indication. The patient previously took Ventolin Evohaler for bronchitis from unknown date to unknown date. (Used Ventolin Evohaler for 6 years after the hospitalization. Over the years, "I have not experienced any breathing issues and stopped using Evohaler completely"). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, after the vaccination, the patient experienced sore left arm for 6 days. On 08Apr2021 at 10:00, the patient experienced mild itchy hives on the neck that was still present on 09Apr2021. On 09Apr2021 in the morning, the patient experienced diarrhea. The patient did not receive any treatment for the events. The clinical outcome of the event sore left arm was recovered on an unknown date in Apr2021 and of the event mild itchy hives on the neck and diarrhea were recovering.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vaccination site pain
Clinical narrative: Some diarrhea; Extreme pain at site injection point.; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on 07Apr2021 at 16:00 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included cholesterol levels had stabilized and arthritis in right hip. The patient had no known allergies to medications, food, or other products. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN) and lovastatin (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 04Mar2021 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 16:00, the patient experienced extreme pain at site injection point that lingered until 08Apr2021 and on 09Apr2021, in morning, the patient's arm felt fine. On 09Apr2021, the patient experienced some diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events extreme pain at site injection point and some diarrhea was resolved on 09Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Pruritus, Throat tightness
Clinical narrative: Itching (moderate) total all body; lump in throat; slight tightness in throat; This is a spontaneous report from a contactable nurse, the patient. A 62-year-old non-pregnant female patient received the unknown dose number of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 at 14:30 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included mad deaf, seizures-simple partial from head trauma, migraines. The patient was allergic to eggs, pesticides, sulfa and ampicillin. Concomitant medications included valproate semisodium (DEPAKOTE), levetiracetam (KEPPRA), topiramate (QUDEXY) and duloxetine hydrochloride (CYMBALTA) from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 14:30, the patient experienced Itching (moderate) total all body with lump in throat and slight tightness in throat. Therapeutic measures were taken as a result of the Itching (moderate) total all body with lump in throat and slight tightness in throat included treatment with 50 mg of Benadryl, when she went home. The clinical outcome of the events Itching (moderate) total all body with lump in throat and slight tightness in throat was recovered on an unknown date in April2021.   No follow-up attempts are needed. information about the lot number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Really achy and sore in left arm; A headache; I have some achiness in my right leg; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 08Apr2021 at 12:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included my right leg that I broke last year and I have a metal rod and screws in it. The patient had no known allergies to medications, food or other products. The patient did not receive any concomitant medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021 at 09:00 the patient experienced really achy and sore in left arm, a headache, patient had some achiness in right leg that broke last year and had a metal rod and screws in it. Therapeutic measures were taken as a result of reported events which included treatment with ibuprofen (MANUFACTURER UNKNOWN) and heating pad and it was helping. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the events really achy and sore in left arm, a headache and achiness in my right leg were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Lip swelling, Swelling face, Urticaria
Clinical narrative: experienced numbness on one side of my face and lip; experienced numbness on one side of my face and lip; It also swelled a bit; It also swelled a bit/ mostly lipand lip area.; broke out in welts/hives on my torso; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733), via an unspecified route of administration on 05Apr2021 at 10:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient had medical history of known allergies to shellfish. Concomitant medications included ethinylestradiol, ferrous fumarate and norethisterone acetate (BLISOVI BIRTH CONTROL PILLS), from an unknown date for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 08Apr2021 at 21:00, 3 days after receiving the vaccine, the patient experienced numbness on one side of her face and lip and it also swelled a bit. The patient also reported that it was just on her right side, mostly lip and lip area and also broke out in welts/hives on her torso. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of numbness on one side of her face and lip, it also swelled a bit and also broke out in welts/hives on her torso was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Chills; Fever; Headache; Fatigue; This is a spontaneous report from a contactable consumer. A 33-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731), via an unspecified route of administration in the left arm on 06Apr2021 at 11:00 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to medications, food, or other products. The patient did not receive any concomitant medications.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 03:00, the patient experienced chills, fever, headache and fatigue. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, fever, headache and fatigue were resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia, Migraine, Nausea, Pain in extremity
Clinical narrative: Pain in arm,; Numbness down hand; Nauseaus; Dizzy; Triggered migraine; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 09Apr2021 at 10:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications taken within two weeks prior to the vaccination included meloxicam (MOBIC), bupropion hydrochloride (WELLBUTRIN), amlodipine (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D), cyanocobalamin (VITAMIN B12) and ascorbic acid (VITAMIN C) all from unknown date for unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 13:15, the patient experienced pain in arm, numbness down her hand, nauseaus, dizzy and triggered migraine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pain in arm, numbness down her hand, nauseaus, dizzy, and triggered migraine was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache
Clinical narrative: Headache; dizziness; tiredness; This is a spontaneous report from a contactable nurse, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 06Apr2021 at 08:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no allergies to medications, food, or other products. Concomitant medications included blood pressure pill (MANUFACTURER UNKNOWN), from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced headache, dizziness and tiredness. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events headache, dizziness and tiredness were not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Headache, Pain, Tachycardia
Clinical narrative: Headache; Body aches; Metal taste in mouth; Rapid heart rate; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 08Apr2021 at 15:45 (at the age of 53-year-old), as a single dose for COVID-19 immunisation. Medical history included rapid heart rate, colitis and COVID-19. The patient did not have any history of allergies to medications, food, or other products. Concomitant medications included meloxicam (MELOXICAN) and metoprolol (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 few minutes after the vaccination, the patient experienced a metal taste in mouth, later that evening patient had a rapid heart rate and patient felt terrible. On 08Apr2021 at 10:00, the patient had a headache and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the events. The clinical outcome of the events metal taste in mouth, rapid heart rate, head ache and body aches were recovered on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; chills; body aches; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 08Apr2021 at 09:45(at the age of 42-year-old), as a single dose for COVID-19 immunisation. Medical history included diabetic and hypertension. Concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 18Mar2021 at 09:45(at the age of 42-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 09Apr2021 at 06:00, the patient experienced fever, chills and body aches. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On an unknown  date the patient underwent lab tests and procedures which included COVID-19 (Blood test) test and the result was negative. The clinical outcome of the event fever, chills and body aches was not recovered at this time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain, Pyrexia
Clinical narrative: Hurting all over body; Started feeling sick; Running a high Fever; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 05Apr2021 at 14:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included COVID-19 (in Dec2020) and was requested to go into the hospital which the patient chose to go home to be with her family. The patient's concomitant medication included levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication since an unspecified date. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, after the vaccination the patient felt fine. On 06Apr2021 at 15:00, almost 24 hours after the vaccination, the patient started feeling sick. By the night the patient was hurting all over her body and was running a high fever. The patient was worried about getting the 2nd shot on 26Apr2021. Therapeutic measures were not taken as a result of these events. The clinical outcome of the event started feeling sick, hurting all over body and running a high fever was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Headache, Myalgia, Pyrexia
Clinical narrative: Severe muscle aches; headache, major congestion and headache; Stomach pain; slight fever for about 4 hours; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 08Apr2021 at 12:45 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included lupus, Sjogren's, migraine, and methicillin-resistant staphylococcus aureus infection (MRSA) and skin infection. The patient received unspecified medication within two weeks of vaccination. The patient had allergies to (unspecified) medications, food or other products. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Mar2021 at 12:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 08Apr2021 at 19:00, the patient experienced severe muscle aches, headache, stomach pain, major congestion and headache and a slight fever for about 4 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with lidocaine and ibuprofen. The clinical outcome of the event slight fever was recovered on 08Apr2021 and of the severe muscle aches, stomach pain, headache, major congestion and headache was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hive like rash that started on feet and spread up both legs, stomach, chest, shoulders and arms; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 01Apr2021 at 09:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergy. Concomitant medications included diphenhydramine hydrochloride (BENADRYL) from an unknown date for seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 08:00, the patient experienced hive like rash that started on feet and had now spread up both legs, stomach, chest, shoulders and arms. Therapeutic measures were taken as a result of the events and included treatment with prednisone. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event hive like rash that started on feet and has now spread up both legs, stomach, chest, shoulders and arms was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Chills, Fatigue, Myalgia
Clinical narrative: Fever; chills; upset stomach; all over muscle and joint pain; all over muscle and joint pain; fatigue; injection bruising; This is a spontaneous report from a contactable other healthcare professional, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 08Apr2021 at 12:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, known allergy to narcotics and COVID-19. The patient did not take any concomitant medications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 07:00, the patient experienced fever, chills, upset stomach, all over muscle and joint pain, fatigue and injection bruising. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events of fever, chills, upset stomach, all over muscle and joint pain, fatigue and injection bruising were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site bruising
Clinical narrative: Fever; chills; upset stomach; all over muscle and joint pain; all over muscle and joint pain; fatigue; injection bruising; This is a spontaneous report from a contactable other healthcare professional, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 08Apr2021 at 12:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, known allergy to narcotics and COVID-19. The patient did not take any concomitant medications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 07:00, the patient experienced fever, chills, upset stomach, all over muscle and joint pain, fatigue and injection bruising. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events of fever, chills, upset stomach, all over muscle and joint pain, fatigue and injection bruising were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Vomiting
Clinical narrative: Threw up at least 4 times; Diarrhea; Cold chills; Real tired; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 08Apr2021 at 10:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issues. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 08Apr2021 at 14:00, the patient threw up at least 4 times, diarrhea, cold chills and was really tired. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of threw up at least 4 times, diarrhea, cold chills and real tired was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia, Vaccination site pain
Clinical narrative: Fever of 101.5; Injection site pain; Headache; Chills; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the arm left on 08Apr2021 at 11:45 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 18Mar2021 at 11:45 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 22:30, the patient experienced injection site pain, headache, chills. On 09Apr2021, next morning upon waking up the patient experienced a fever of 101.5. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events injection site pain, headache, chills and fever of 101.5 was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Headache, Nausea
Clinical narrative: 3 hours after I received the vaccine my blood pressure raised to 160/100 (I never had high blood pressure before) due to the spike in blood pressure I had headache and nausea. The blood pressure slowly went back to normal after a few hours; 3 hours after I received the vaccine my blood pressure raised to 160/100 (I never had high blood pressure before) due to the spike in blood pressure I had headache and nausea. The blood pressure slowly went back to normal after a few hours; 3 hours after I received the vaccine my blood pressure raised to 160/100 (I never had high blood pressure before) due to the spike in blood pressure I had headache and nausea. The blood pressure slowly went back to normal after a few hours; This is a spontaneous report from a contactable pharmacist, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 00:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to food, medicine or other products. The patient did not receive any medication within two weeks prior to vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 16:00, three hours after the patient received the vaccine, her blood pressure raised to 160/100 (units unspecified) (The patient never had high blood pressure before) due to the spike in blood pressure she had headache and nausea. The blood pressure slowly went back to normal after a few hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events three hours after the patient received the vaccine her blood pressure raised to 160/100 (units unspecified) (The patient never had high blood pressure before) due to the spike in blood pressure she had headache and nausea, the blood pressure slowly went back to normal after a few hours was resolving at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Breast swelling, Lymphadenopathy
Clinical narrative: Thursday 4/8/21 evening I started feeling a pain in my left armpit and let side of my breast.; Thursday 4/8/21 evening I started feeling a pain in my left armpit and let side of my breast./ Under my left arm, armpit and left side of breast is swollen and hurts; Under my left arm, armpit and left side of breast is swollen and hurts; Left side of breast was swollen; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 07Apr2021 at 11:45(at the age of 57-year-old) as a single dose for COVID-19 immunization. Medical history included shellfish allergy, fruit allergy and penicillin allergy. Concomitant medications included liraglutide (SAXENDA) for unknown indication and from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm left on 17Mar2021 at 11:45 (at the age of 57-year-old) as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 18:00, Thursday evening the patient started feeling a pain in the left armpit and left side of the breast. Under the left arm, armpit and left side of breast was swollen and was hurting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event pain in the left armpit and left side of the breast, Under the left arm, armpit and left side of breast swollen and hurting was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Nasal congestion
Clinical narrative: Joint pain; congestion; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EP6955) via an unspecified route of administration in the left arm on 08Apr2021 at 15:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid disease. Concomitant medications included levothyroxine sodium (SYNTHROID) since an unknown date for an unknown indication. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EP6955) via an unspecified route of administration in the left arm on 18Mar2021 at 15:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient had no known allergies to food, medications or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021, day after the second dose of vaccination at 10:00 the patient experienced joint pain and congestion. The patient did not receive any treatment for the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events joint pain and congestion was not recovered at the time of  this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Axillary pain
Clinical narrative: pain under right armpit; swelling under right armpit; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 07Apr2021 at 16:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included unspecified birth control, unspecified allergy medications; all for unknown indication from unknown start date. The patient had no allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 02:00, the patient woke up with pain and swelling under right armpit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event pain under right armpit and swelling under right armpit was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Headache, Myalgia, Product administered at inappropriate site
Clinical narrative: vaccine location=Left leg; Extreme muscle aches; Chills; Headache; Shakes; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left leg on 06Apr2021 at 14:00 (at the age of 67-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, heart condition, known allergy to penicillin and COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO), olmesartan (MANUFACTURER UNKNOWN), rosuvastatin calcium (CRESTOR), metoprolol (MANUFACTURER UNKNOWN) and clopidogrel (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 02:00,12 hours after shot, the patient experienced extreme muscle aches, chills, headache, shakes and loss of appetite for about 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events extreme muscle aches, chills, headache, shakes and loss of appetite were recovered on 08Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: vaccine location=Left leg; Extreme muscle aches; Chills; Headache; Shakes; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left leg on 06Apr2021 at 14:00 (at the age of 67-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, heart condition, known allergy to penicillin and COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO), olmesartan (MANUFACTURER UNKNOWN), rosuvastatin calcium (CRESTOR), metoprolol (MANUFACTURER UNKNOWN) and clopidogrel (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 02:00,12 hours after shot, the patient experienced extreme muscle aches, chills, headache, shakes and loss of appetite for about 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events extreme muscle aches, chills, headache, shakes and loss of appetite were recovered on 08Apr2021.   No follow-up attempts are possible. No further information is expected.